Form 4 for PRVA Privia Health Group, Inc.
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0001759655-24-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-22 | PRVA | KING DAVID P | Dir | A - Grant | $0.00 | +11.1K | 33.9K | +49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2024-05-22 | A | A | 11,124 | $0.00 | 33,916 | D | — | — | (F1) On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant |